Mv. Bor et al., Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction, ACT CARDIOL, 54(5), 1999, pp. 271-276
Objective - Selenium (Se) is part of the enzyme glutathione peroxidase (GSH
-Px) that plays an important role in the antioxidant defence of the body, i
ncluding the myocardium, against the deleterious actions of free radicals a
nd lipid peroxides. In order to evaluate the Se status and the GSH-Px activ
ity in ischaemic heart disease, plasma, erythrocyte and urinary Se concentr
ations together with plasma and erythrocyte GSH-Px activities were determin
ed in 27 patients diagnosed as acute myocardial infarction (AMI). The contr
ol group consisted of 24 age-matched healthy individuals.
Methods and results - Fasting blood and urine samples were collected within
24 hours after the onset of chest pain. Mean plasma, erythrocyte and urine
Se concentrations were significantly lower in the patient groups (63.7 +/-
12 mu g/l, 0.48 +/- 0.04 mu g/g Hb and 49.6 +/- 27.7 mu g/g creatinine, re
spectively), compared to controls (82.2 +/- 14.6 mu g/l, 0.51 +/- 0.03 mu g
/g Hb and 93.4 +/- 62.6 mu g/g creatinine, p < 0.001, p < 0.02 and p < 0.00
3, respectively). No statistically significant difference was found between
mean plasma GSH-Px activity in patients (0.36 +/- 0.1 U/ml) and controls (
0.35 +/- 0.09 U/ml), whereas erythrocyte GSH-Px activity was higher in pati
ents (48.1 +/- 10.2 U/g Hb) than in the controls (35.3 +/- 9.1 U/g Hb, p <
0.001).
Conclusion - Our findings confirm the previous studies and demonstrate that
patients suffering from AMI exhibit lower plasma, erythrocyte and urinary
Se than the controls. Since the erythrocyte Se level represents a measure o
f the Se status over a period of several weeks due to its long biological h
alf-life, low Se levels observed in the patient group might have been prese
nt before the acute event, thereby suggesting an aetiologic relevance. The
presence of increased erythrocyte GSH-Px activity in these patients may be
interpreted as an antioxidant defence against the chronic oxidant stress pr
esent before the AMI, presumably due to the process of coronary atheroscler
osis.